A Prospective, Randomized, Phase III Trial of FLAC (5-Fluorouracil, Leucovorin, Adriamycin, Cytoxan) Chemotherapy With GM-CSF (Granulocyte-Macrophage Colony-Stimulating Factor) Versus PIXY 321 in Advanced Breast Cancer - Related Studies

A Prospective, Randomized, Phase III Trial of FLAC (5-Fluorouracil, Leucovorin, Adriamycin, Cytoxan) Chemotherapy With GM-CSF (Granulocyte-Macrophage Colony-Stimulating Factor) Versus PIXY 321 in Advanced Breast Cancer

This study has been completed.

Study NCT00001338. Last updated on March 3, 2008. Information provided by National Institutes of Health Clinical Center (CC)

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:


1	Conditions listed in this trial
		Breast Neoplasms
		Fever
		Hematologic Diseases
		Neutropenia
		Sepsis

2	More general conditions related to this trial
		Agranulocytosis
		Breast Diseases
		Leukocyte Disorders
		Leukopenia
		Neoplasms
		Neoplasms by Site
		Skin Diseases

3	Interventions listed in this trial
		FLAC chemotherapy with GM-CSF

4	Additional drug interventions recognized in this trial
		Fluorouracil

5	More general drug interventions related to this trial
		Antimetabolites
		Antimetabolites, Antineoplastic
		Antineoplastic Agents
		Immunologic Factors
		Immunosuppressive Agents
		Molecular Mechanisms of Pharmacological Action
		Pharmacologic Actions
		Physiological Effects of Drugs
		Therapeutic Uses

6	Sponsors listed in this trial
		National Cancer Institute (NCI)